Skip to main content
Monday, November 16, 2026Nov 16

FDA approves new higher-dose version of Wegovy shots

FILE - The Food and Drug Administration seal is seen at the Hubert Humphrey Building Auditorium in Washington, April 22, 2025. (AP Photo/Jose Luis Magana, File)
FILE - The Food and Drug Administration seal is seen at the Hubert Humphrey Building Auditorium in Washington, April 22, 2025. (AP Photo/Jose Luis Magana, File)

Federal regulators on Thursday approved a new higher-dose version of the blockbuster obesity drug Wegovy that may help users lose more weight and keep it off.

The U.S. Food and Drug Administration approved a 7.2-milligram dose of Danish drugmaker Novo Nordisk’s semaglutide. Previously, the highest approved dose of the drug, taken as a weekly shot, was 2.4 milligrams.

The new dose received accelerated review through the FDA’s ultra-fast drug review program. The approval was granted 54 days after the request for review was approved, the agency said in a statement.

The new dosage will be available in April at pharmacies in the U.S., with a price to be announced then, according to the company.

European drug regulators approved the higher-dose version of Wegovy in February.